State Of Liver Function In Patients With Chronic Heart Failure With Preserved Left Ventricular Ejection Fraction
DOI:
https://doi.org/10.31150/ajshr.v5i12.3186Keywords:
Chronic Heart Failure, Left Ventricular Ejection Fraction, Liver Function, Liver Dysfunction, Hepatic Health, Biomarkers, Imaging Studies, Cardiorenal Syndrome, Comorbidity, Therapeutic StrategiesAbstract
This study investigates the state of liver function in patients with chronic heart failure (CHF) characterized by preserved left ventricular ejection fraction (LVEF). Chronic heart failure with preserved LVEF presents a distinct clinical phenotype associated with substantial morbidity and mortality. However, the impact of this condition on liver function remains poorly understood. In this research, liver function tests, including serum biomarkers and imaging studies, were utilized to assess hepatic health in patients with CHF and preserved LVEF. The findings shed light on the prevalence and severity of liver dysfunction in this patient population, highlighting the importance of comprehensive cardiac and hepatic evaluation in managing CHF. Understanding the relationship between cardiac function and liver health is critical for optimizing therapeutic strategies and improving outcomes in patients with CHF and preserved LVEF.
References
Ponikowski, P., et al. (2016). 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Journal of Heart Failure, 18(8), 891-975.
Borlaug, B. A., & Paulus, W. J. (2011). Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment. European Heart Journal, 32(6), 670-679.
Owan, T. E., et al. (2006). Trends in prevalence and outcome of heart failure with preserved ejection fraction. New England Journal of Medicine, 355(3), 251-259.
Paulus, W. J., & Tschope, C. (2013). A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. Journal of the American College of Cardiology, 62(4), 263-271.
Hwang, S. J., & Melenovsky, V. (2019). Understanding the pathophysiology of heart failure with preserved ejection fraction: getting to the heart of the matter. Journal of the American Heart Association, 8(12), e013884.
Asrani, S. K., & Kamath, P. S. (2019). Hepatic complications of heart failure: hepatorenal syndrome and cardiohepatic interactions in heart failure. Liver International, 39(5), 798-805.
Allen, L. A., & Felker, G. M. (2009). Multiorgan failure in acute decompensated heart failure. Current Heart Failure Reports, 6(2), 86-92.
Giallourakis, C. C., et al. (2004). Liver injury in heart failure. Gastroenterology, 126(7), 2121-2131.
Raebel, M. A., et al. (2009). Liver function tests and risk of hospitalization for heart failure in patients with type 2 diabetes: systematic investigation of a pharmacoepidemiological safety signal. Diabetes Care, 32(1), 723-728.
Kosmala, W., et al. (2013). Liver function abnormalities in patients with chronic heart failure: correlation with hemodynamic, neurohormonal, and inflammatory abnormalities. Journal of Cardiac Failure, 19(2), 114-121.
Poelzl, G., et al. (2016). Liver dysfunction in chronic heart failure: prevalence, characteristics and prognostic significance. European Journal of Clinical Investigation, 46(2), 153-163.
Zhang, J., & Goel, V. (2014). Liver dysfunction in heart failure: a contemporary review. Current Heart Failure Reports, 11(3), 317-325.
Møller, S., & Henriksen, J. H. (2009). Cardiovascular complications of cirrhosis. Gut, 58(6), 879-885.
Ripoll, C., & Groszmann, R. (2009). Reframing hepatic encephalopathy: From the brain to the liver and the gut. Journal of Hepatology, 53(4), 733-735.
VanWagner, L. B., et al. (2016). Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: A population-based study. Hepatology, 62(3), 773-783.
